ID

18868

Beskrivning

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

Nyckelord

  1. 2016-11-15 2016-11-15 -
  2. 2016-11-23 2016-11-23 -
Uppladdad den

23 november 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC-ND 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    WTZ-GIST-09-01 (Imatinib + LBH589) Cover Sheet 2009-011417-24 DRKS00000657

    WTZ-GIST-09-01 (Imatinib + LBH589) Cover Sheet 2009-011417-24

    Patient Data
    Beskrivning

    Patient Data

    Alias
    UMLS CUI-1
    C2707520
    Patient No.
    Beskrivning

    Patient number

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C2348585
    Cohort
    Beskrivning

    Cohort

    Datatyp

    integer

    Alias
    UMLS CUI [1]
    C0599755

    Similar models

    WTZ-GIST-09-01 (Imatinib + LBH589) Cover Sheet 2009-011417-24

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Patient Data
    C2707520 (UMLS CUI-1)
    Patient number
    Item
    Patient No.
    text
    C2348585 (UMLS CUI [1])
    Item
    Cohort
    integer
    C0599755 (UMLS CUI [1])
    Code List
    Cohort
    CL Item
    10 mg LBH589 (-1)
    CL Item
    20 mg LBH589 (0)
    CL Item
    30 mg LBH589 (1)
    CL Item
    40 mg LBH589 (2)

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial